BoulosASLevyEI: Evolution of neuroendovascular intervention: A review of advancement in device technology. Neurosurgery54: 438–453, 2004.
2.
FlorioFLauriolaW: Endovascular treatment of intracranial arterio-venous malformations with Onyx embolization: preliminary experience. Radiol Med106: 512–520, 2003.
3.
HowingtonJUKerberCW: Liquid embolic agents in the treatment of intracranial arteriovenous malformations. Neurosurg Clin N Am16: 355–363, 2005.
4.
JahanRMurayamaY: Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery48: 984–985, 2001.
5.
SongDLengB: Onyx in the treatment of large and giant aneurysms and arteriovenous malformations. Chines Medical Jounal117: 1869–1872, 2004.
6.
TaylorCLDuttonK: Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg100: 810–812, 2004.
7.
MolyneuxAJChirB: Embolization of spinal cord arteriovenous malformations with an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (Onyx liquid embolic system). J Neurosurg93: 304–308, 2000.
8.
WarakaulleDRAvivRI: Embolization of spinal dural arteriovenous fistulae with Onyx. Neuroradiology45: 110–112, 2003.
9.
GobinYPMurayamaY: Head and neck hypervascular lesions: Embolization with ethylene vinyl alcohol copolymer — Laboratory evaluation in swine and clinical evaluation in humans. Radiology221: 309–317, 2001.
10.
NumanFOmerogluA: Embolization of peripheral vascular malformations with ethylene vinyl alcohol copolymer (Onyx). JVIR15: 939–946, 2004.
11.
AbdalaNLevitinA: Use of ethylene vinyl alcohol copolymer for tubal sterilization by selective catheterization in rabbits. JVIR12: 979–984, 2001.
12.
HamadaJYutakaK: A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study. J Neurosurg97: 889–895, 2002.
13.
WrightKCGreffRJ: Experimental evaluation of cellulose acetate NF and ethylene-vinyl alcohol copolymer for selective arterial embolization. J Vasc Interv Radiol10: 1207–1018, 1999.
14.
MassoudTFJiC: An experimental arteriovenous malformation model in swine: Anatomic basis and construction technique. Am J Neuroradiol15: 1537–1545, 1994.
15.
MurayamaYViñuelaF: Nonadhesive liquid embolic agent for cerebral arteriovenous Malformations: Preliminary histopatholigical studies in swine rete mirabile. Neurosurgery43: 1164–1175, 1998.
16.
ChaloupkaJHuddleD: A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. Am J Neuroradiol20: 401–410, 1999.
17.
SugiuKNishidaA: The long-term follow-up patients treated with liquid embolic agent dissolved in dimethyl sulfoxid (DMSO). Oral Presentation at the WITNC, Seoul, September 2001.
18.
LaragesALobatoRD: Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients (comment). Neurosurgery51: 1525–1526, 2002.
19.
AkinEDPerkinsE: Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with n-butyl cyanoacrylate used for embolization of vessels in an arteriovenous resection model in swine. J Neurosurg98: 366–370, 2003.
20.
DuffnerFRitzR: Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Clin Neuropathol21: 13–17, 2002.